Showing results (1541-1550 of 1,948) with videos related to

Sort By:
Pageof 195
Diabetes, Obesity & Metabolism|July 8, 2016
Efficacy and safety of triple therapy with dapagliflozin add-on to saxagliptin plus metformin over 52 weeks in patients with type 2 diabetesC Mathieu, M Herrera Marmolejo, J G González González, et al.
Biotechniques|November 1, 1991
Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technologyU Jönsson, L Fägerstam, B Ivarsson, et al.
Clinical and Translational Allergy|January 9, 2025
Prednisolone versus antihistamine for allergic rhinitis: No significant difference found in randomized trialCarl Skröder, Laila Hellkvist, Ulla Westin, et al.
Journal of the American Chemical Society|July 22, 2024
Fluorogenic Rhodamine-Based Chemigenetic Biosensor for Monitoring Cellular NADPH DynamicsHuimin Chang, Simon Clemens, Pingting Gao, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 26, 2021
Albuterol/budesonide for the treatment of exercise-induced bronchoconstriction in patients with asthma: The TYREE studyCraig LaForce, Bradley E Chipps, Frank C Albers, et al.
Nature Communications|April 28, 2022
A synergistic strategy to develop photostable and bright dyes with long Stokes shift for nanoscopyGangwei Jiang, Tian-Bing Ren, Elisa D'Este, et al.
International Journal of Pediatric Otorhinolaryngology|July 20, 2002
Language development in hearing-impaired children. Establishment of a reference material for a 'Language test for hearing-impaired children', LATHICErik Borg, Arne Risberg, Bob McAllister, et al.
Environmental Pollution (Barking, Essex : 1987)|September 4, 2020
Urban noise restricts, fragments, and lightens sleep in Australian magpiesFarley Connelly, Robin D Johnsson, Anne E Aulsebrook, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 27, 2018
Characterization of the Open-Label Lead-In Period of Two Randomized Controlled Phase 3 Trials Evaluating Dapagliflozin, Saxagliptin, and Metformin in Type 2 DiabetesChantal Mathieu, Doina Catrinoiu, Aurelian Emil Ranetti, et al.
Pageof 195